According to GlobalData’s medical device pipeline database, seven Copper IUDs devices are in various stages of development globally. GlobalData’s report Copper IUDs provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, four are in active development, while the remaining three are in an inactive stage of development. There are two products in the early stages of development, and the remaining two are in the late stages of development.

Copper IUDs contain copper wires that are coiled around the IUD. Copper IUDs are source of copper elicits inflammation that kills sperm and eggs, thus preventing pregnancy. One unit refers to one Copper IUD.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Copper IUDs pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Copper IUDs devices. Overall, most of these Copper IUDs pipeline devices are being developed by private entities.

Key players involved in the active development of Copper IUDs include OCON Medical, Otago Innovation, Sebela Pharmaceuticals, University of Washington, 3Daughters and HLL Lifecare.

For a complete picture of the developmental pipeline for Copper IUDs devices, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.